Skip to content
HighLife Medical Logo
Menu
  • Home
  • About Us
  • Mitral Valve Insufficiency
  • Technology
  • Healthcare Professionals
    • Physician Feedback
    • Scientific Meetings
    • Publications
  • News
  • Contact

Category: Corporate

Corporate

January 17, 2019 – HighLife Closes a €32 Million Round B Financing

HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral regurgitation, announced today it had closed a € 32 …

Corporate

May 9, 2018 – HighLife appoints Dr. Martin Rothman as independent member of the board

HighLife SAS, a medtech company focused on the development of a unique trans- catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment …

Corporate

Dec. 8, 2017 – HighLife appoints Jose Calle Gordo as Chairman of the Board

HighLife SAS, a medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the appointment of …

Corporate

Oct. 30, 2017 – HighLife closes €12.3 million financing round led by Sofinnova Partners

This financing allows for the acceleration of the company’s clinical and R&D program HighLife SAS, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement …

Copyright © 2019 HIGHLIFE MEDICAL – OnePress theme by FameThemes